Dr. Catherine Guettier has played a leading role in adopting and implementing digital pathology across hospitals in France. Read her reflections from Aiforia’s blog: hubs.la/Q03hMHsW0

Digital pathology is pivotal to improving healthcare, both in the research and clinical sectors. Learn more about its advantages in our new blog post: hubs.la/Q03lztCq0

The Nantes University Hospital in France has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in pathology: hubs.la/Q03n5p-h0

Aiforia has appointed pathologist Richard Doughty (MD, DVM, MSc) as the company's Medical Director. With this new position, Aiforia aims to strengthen its leadership with enhanced medical expertise. Read more: hubs.la/Q03p3q9G0

We are excited to attend the upcoming 21st European Congress on Digital Pathology (ECDP) in Barcelona. 🖥️ Experience Aiforia's broadest collection of AI models in pathology and see it in action at booth 51: hubs.la/Q03qF4WR0 #ECDP #ECDP2025 #pathology #digitalpathology

On June 12-13, we are at the 48th Pathology Conference in Toulouse, France. Meet our team at booth 10 to discover more about Aiforia’s solutions for AI-assisted image analysis and see a live demo. Would like to learn more? Get in touch ➡️ hubs.la/Q03rPmVN0

21st European Congress on Digital Pathology (ECDP), organized by the @European Society of Digital and Integrative Pathology (ESDIP in Barcelona, is less than 2 weeks away. Some highlights to look forward to: hubs.la/Q03rR-NQ0 #ECDP #ECDP2025 #pathology #digitalpathology

Join Aiforia's webinar on Monday, June 23, to delve deeper into the real-world diagnostic pressure points of PD-L1 TPS testing in NSCLC. Register here: hubs.la/Q03sn6SF0

Explore a new publication where the Aiforia® Platform was used for AI-driven histological analysis of fish skin: hubs.la/Q03sQ9NY0 Congratulations to Lene Sveen and the whole team on their great work!

📢 NEWS: Aiforia releases a new CE-IVD-marked clinical AI solution for breast cancer diagnostics. Read the announcement here: hubs.la/Q03thHP50 #pathology #digitalpathology #CE-IVD #cancerdiagnostics #breastcancer #AI #medicalnews

Greetings from the #ECDP2025 in Barcelona! Join Aiforia's session at the "Digital pathology showcase 2025: unlocking interoperability" today. Visit our booth 51 to experience Aiforia's broadest collection of AI models in pathology and see it in action with a live AI demo.

Dr. Camille Hurley, PhD, a Translational Oncology Researcher based in the Department of Surgery at Trinity Translational Medicine Institute in Dublin, Ireland, used Aiforia® Create to develop two AI models for predicting the pathological complete response in HER2+ breast cancer.

Last week, we had a great time at the 21st European Congress on Digital Pathology (ECDP). There were many interesting and insightful discussions, presentations, and posters. Big thanks to everyone who visited Aiforia's booth and joined our showcase and AI Innovation Pitch.✨

Aiforia Technologies Plc has established a subsidiary in France to strengthen its local presence and to support its growing business in the country. Read more ➡️ hubs.la/Q03wnZkC0

🇫🇷 Joyeux 14 Juillet à tous! Today, in the light of Bastille Day (French National Day), we're celebrating the spirit of liberty, unity, and resilience that defines France. Read more about our expanding presence in France here: hubs.la/Q03x0wB_0

Histological grade in breast cancer provides important prognostic information for treatment decisions. Read our new blog post to learn how AI can harmonize breast cancer grading: hubs.la/Q03xsFSc0

Memorial Pathology implemented Aiforia® Clinical Suites for breast, prostate, and PD-L1 lung to gain efficiency and accuracy in the routine workflow. Learn more: hubs.la/Q03xYHxf0

AI can streamline prostate cancer pathology workflows, accelerating the detection of high-risk features that predict metastatic potential. Learn more: hubs.la/Q03xYDlw0